Eco Animal Health revenues offset by rising costs
Eco Animal Health, which specialises in the development and marketing of medicines for the control of disease in livestock, saw its pre-tax profit for the year creep higher after revenue gains were slightly offset by rising sales costs.
Eco Animal Health, which specialises in the development and marketing of medicines for the control of disease in livestock, saw its pre-tax profit for the year creep higher after revenue gains were slightly offset by rising sales costs.
Pre-tax profit was £2.32m (2011: £2.29m) on revenues of £28.3m (2011: £27.1m), while the cost of sales increased from £16.4m to £17.5m year-on-year.
A small amount of additional income (£0.76m compared to £0.18m the previous year) helped to boost profits higher.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Diluted earnings per share were 4.19p against 2.96p the previous year, with income pushed higher by the continued growth of the consumption of meat protein and the animal industry.
UK sales grew more than 30% during the year, reflecting the continued success of its direct-to-market strategy with its Aivlosin product.
Peter Lawrence, Executive Chairman of ECO Animal Health Group, said: "ECO has delivered another strong set of results for the year ended March 31st and the current year has started well.
"We are confident that the long awaited marketing authorisations in the US and Canada will have a major positive effect on the development of ECO, although it will be some months before the product launches gain momentum. We do not expect a noticeable impact on our financial performance until next year.
"ECO is very well placed to further broaden its product ranges and its global reach will ensure that it capitalises on opportunities as they arise in all the Company's major markets."
The share price fell 0.39% o 256.50p by 12:10.
NR
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Watch out for fake Steven Bartlett video – you could lose thousands
Scammers are trying to tap into the Trump tariffs chaos, but knowing what to look out for could save you thousands of pounds, says Kalpana Fitzpatrick
By Kalpana Fitzpatrick
-
Can Donald Trump fire Jay Powell – and what do his threats mean for investors?
Donald Trump has been vocal in his criticism of Jerome "Jay" Powell, chairman of the Federal Reserve. What do his threats to fire him mean for markets and investors?
By Katie Williams